Search Blog
December 2013
« Nov   Jan »


Interest Stock Analysis: Gilead Sciences, Acura Pharmaceuticals, Barnes & Noble, Micron Technology


By PrimeTimeMedia LLC

New York, December 09, 2013 /Accesswire/ – Market Buzz Report, a leading penny stock newsletters provider, issues major news alert for Gilead Sciences, Inc.(NASDAQ:GILD), Acura Pharmaceuticals, Inc.(NASDAQ:ACUR), Barnes & Noble, Inc.(NYSE:BKS), Micron Technology, Inc. (NASDAQ:MU).

Fresh off FDA approval for the game-changing HCV treatment
sofosbuvir, Gilead Sciences, Inc.(NASDAQ:GILD) reports (at ASH) interim results
from a Phase 2 study of the Syk inhibitor GS-9973 in relapsed or refractory
hematologic malignancies. Results: 97% of CLL patients receiving at least eight
weeks of therapy saw lymph node reduction, 20% saw a 50% or greater reduction
in their tumors, and, regarding safety, in a population of 78 CLL and NHL
patients receiving at least four weeks of therapy, 64% continued treatment.
(PR)Also at ASH, GILD reported results from a Phase 2 study of the PI3K
inhibitor idelalisib in refractory iNHL. OR rate: 57%, medium duration 12.5
months; CRs, 6%; 63% had a partial response. Median PFS: 11 months; median OS,
20.3 months.

Free Urgent Insider Catalyst Report For GILD Available Here: (Or Copy and paste the URL into your browser)

Acura Pharmaceuticals, Inc.(NASDAQ:ACUR) shares surge 5% after the FDA agrees to review the results of the failed Phase II trial of a painkiller that was made with the company’s Aversion technology, which is designed to deter drug abuse. The results of the study showed that Acura’s tablet did not significantly lower likability among abusers. The FDA has now agreed to provide a definitive response regarding the suitability of the study that will be used to consider authorization of Acura’s product. The agency has requested extra data, although the company doesn’t believe it will need to carry out additional studies.

Free Urgent Insider Catalyst Report For ACUR Available Here: (Or Copy and paste the URL into your browser) 

Shares of Barnes & Noble, Inc.(NYSE:BKS) take off as a couple of analysts back the company to come out the other side of a SEC probe over accounting in decent shape. The somewhat twisted logic is that the company’s retail bookstore business may be in even better shape than realized if it’s been bearing more Nook-related costs than it should have been. 

Free Urgent Insider Catalyst Report For BKS Available Here: (Or Copy and paste the URL into your browser) 

Micron Technology, Inc. (NASDAQ:MU) shares climbed 3.05% to $23. The company on Dec. 2 announced that the company has named Rajan Rajgopal, vice president of Quality. Rajgopal will be responsible for overseeing all aspects of Micron’s quality systems including manufacturing, customer program management and product ramps. He brings more than 25 years of experience to Micron and most recently served as the vice president of Global Quality and Customer Enablement for GLOBALFOUNDRIES in Singapore.

Free Urgent Insider Catalyst Report For MU Available Here: (Or Copy and paste the URL into your browser) is an investment community that focuses on MicroCap Securities. is an authorative authentic Google News Site and Leading Provider of Investment Awareness and Featured Company Profiles. If you would like more information regarding our news coverage solutions, please visit for more details. Get an edge on the market with our Premium News Alerts that are FREE for a limited time at

Follow us on Facebook:

Sign up for our FREE SMS News alerts delivered directly to your mobile phone by texting the word PREPROMO to 27126 (SMS alerts are free, however data rates may apply, check your wireless plan for details.).